Atherosclerosis Risk in Communities

Atherosclerosis Risk in Communities. This long-term epidemiological study, sponsored by the National Heart, Lung, and Blood Institute, was initiated in 1987 to investigate the causes of atherosclerosis and its clinical outcomes. It focuses on understanding the progression of cardiovascular disease in community-dwelling adults across four distinct U.S. communities. The ARIC study has been instrumental in identifying risk factors and shaping modern preventive cardiology.

Study Design and Objectives

The ARIC study employs a prospective cohort study design, with the primary aim of elucidating the natural history and etiology of atherosclerosis. Key objectives included measuring subclinical disease progression through methods like carotid ultrasonography and investigating disparities in coronary heart disease incidence between communities and racial groups. The study was designed to provide robust data on the relationships between lipid levels, blood pressure, diabetes, and genetic factors with cardiovascular outcomes. Its design has served as a model for subsequent large-scale investigations like the Multi-Ethnic Study of Atherosclerosis.

Participant Characteristics and Recruitment

Recruitment occurred between 1987 and 1989 across four field centers representing diverse populations. These included a biracial cohort from Forsyth County, North Carolina, an exclusively African American cohort from Jackson, Mississippi, and predominantly White American cohorts from suburbs of Minneapolis and Washington County, Maryland. In total, approximately 15,800 individuals aged 45–64 were enrolled. The inclusion of the Jackson Heart Study community was critical for examining cardiovascular health in African Americans. Participants underwent extensive baseline examinations at clinics like the Johns Hopkins Hospital and the University of Minnesota.

Major Findings and Contributions

The ARIC study has generated landmark findings that have reshaped medical guidelines. It provided pivotal data validating the clinical utility of measuring C-reactive protein and troponin for risk stratification. Research from ARIC solidified the role of LDL cholesterol and hypertension as major risk factors and highlighted the dangers of obesity and metabolic syndrome. The study also identified significant racial disparities, such as higher rates of stroke and heart failure among African Americans. Its work on atrial fibrillation and chronic kidney disease has been widely cited in journals like the New England Journal of Medicine.

Impact on Cardiovascular Disease Research

ARIC's impact on cardiovascular disease research is profound, having contributed to the evidence base for major prevention guidelines from the American Heart Association and the American College of Cardiology. Its biobank and longitudinal data have enabled thousands of investigations into genomics, proteomics, and metabolomics. The study's framework influenced the design of international efforts like the Framingham Heart Study and the UK Biobank. Findings from ARIC are routinely used by agencies like the Centers for Disease Control and Prevention to inform public health strategies.

Data Access and Ancillary Studies

The National Heart, Lung, and Blood Institute provides broad access to ARIC data and biospecimens through the Biologic Specimen and Data Repository Information Coordinating Center. This has fostered numerous ancillary studies, including investigations into dementia, retinopathy, and hearing loss. Collaborative projects with institutions like the Mayo Clinic and the University of Texas Southwestern Medical Center have expanded the scientific yield. The ongoing follow-up and integration of data from Medicare (United States) ensure the study's continued relevance for understanding aging and chronic disease.

Category:Medical research studies Category:Epidemiology Category:Cardiology